Matches in Wikidata for { <http://www.wikidata.org/entity/Q89154803> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q89154803 description "clinical trial" @default.
- Q89154803 description "ensayu clínicu" @default.
- Q89154803 description "klinisch onderzoek" @default.
- Q89154803 description "клінічне випробування" @default.
- Q89154803 name "Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 name "Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 type Item @default.
- Q89154803 label "Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 label "Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 prefLabel "Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 prefLabel "Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 P1050 Q89154803-A0144669-40E4-4E59-8726-7F3D38256B5E @default.
- Q89154803 P1132 Q89154803-AF7E44F3-7C86-4243-8901-E75E3967D148 @default.
- Q89154803 P1476 Q89154803-97B4FA42-54D6-48F3-AE45-29C7A3608D60 @default.
- Q89154803 P2899 Q89154803-C0F56603-AF1B-449A-8788-C598D68D30E8 @default.
- Q89154803 P3098 Q89154803-95405E60-B772-418B-AB3C-53C9BB5C5BF8 @default.
- Q89154803 P31 Q89154803-5DA3B671-9CFE-4151-8C7B-95DB8750D6A6 @default.
- Q89154803 P4135 Q89154803-65A65A5A-05AE-4222-9014-D17D7155CD07 @default.
- Q89154803 P580 Q89154803-76DF84FD-6F7F-4E4E-890E-29EC2A7B9DB6 @default.
- Q89154803 P582 Q89154803-3C56FB07-102C-4A91-96A5-55AE089C023B @default.
- Q89154803 P6099 Q89154803-2A209ECC-BDAD-490E-99BA-6EFDA6F3D144 @default.
- Q89154803 P8363 Q89154803-C320C625-9166-433C-8E3E-6E6A314FD683 @default.
- Q89154803 P859 Q89154803-F26584DE-D4C3-4C3E-AC78-5161F75DFFBF @default.
- Q89154803 P921 Q89154803-38C09818-81FB-4126-819B-13FFCD596AE7 @default.
- Q89154803 P921 Q89154803-7A5DE0EB-3F85-4B07-9F9F-1AA33355F9F9 @default.
- Q89154803 P921 Q89154803-96D6B0FA-EFBB-4A38-A237-634086E5392E @default.
- Q89154803 P921 Q89154803-C24B8B46-21FE-4CCC-80AC-A1D25CDA2DF6 @default.
- Q89154803 P921 Q89154803-FF5BC95D-AADF-4916-9FD1-7CA731663CE2 @default.
- Q89154803 P1050 Q12156 @default.
- Q89154803 P1132 "+50" @default.
- Q89154803 P1476 "A Randomized, Subject and Investigator-blinded, Placebo Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of KAE609 Administered Intravenously in Healthy Subjects" @default.
- Q89154803 P2899 "+18" @default.
- Q89154803 P3098 "NCT04321252" @default.
- Q89154803 P31 Q30612 @default.
- Q89154803 P4135 "+55" @default.
- Q89154803 P580 "2020-04-15T00:00:00Z" @default.
- Q89154803 P582 "2020-10-14T00:00:00Z" @default.
- Q89154803 P6099 Q5452194 @default.
- Q89154803 P8363 Q78089383 @default.
- Q89154803 P859 Q507154 @default.
- Q89154803 P921 Q10566551 @default.
- Q89154803 P921 Q269829 @default.
- Q89154803 P921 Q323936 @default.
- Q89154803 P921 Q7180915 @default.
- Q89154803 P921 Q7814214 @default.